166 related articles for article (PubMed ID: 37098374)
1. Pulsatility and flow patterns across macro- and microcirculatory arteries of continuous-flow left ventricular assist device patients.
Stöhr EJ; Ji R; Mondellini G; Braghieri L; Akiyama K; Castagna F; Pinsino A; Cockcroft JR; Silverman RH; Trocio S; Zatvarska O; Konofagou E; Apostolakis I; Topkara VK; Takayama H; Takeda K; Naka Y; Uriel N; Yuzefpolskaya M; Willey JZ; McDonnell BJ; Colombo PC
J Heart Lung Transplant; 2023 Sep; 42(9):1223-1232. PubMed ID: 37098374
[TBL] [Abstract][Full Text] [Related]
2. Cerebral vasoreactivity in HeartMate 3 patients.
Stöhr EJ; Ji R; Akiyama K; Mondellini G; Braghieri L; Pinsino A; Cockcroft JR; Yuzefpolskaya M; Amlani A; Topkara VK; Takayama H; Naka Y; Uriel N; Takeda K; Colombo PC; McDonnell BJ; Willey JZ
J Heart Lung Transplant; 2021 Aug; 40(8):786-793. PubMed ID: 34134913
[TBL] [Abstract][Full Text] [Related]
3. Left Ventricular Assist Device Flow Pattern Analysis Using a Novel Model Incorporating Left Ventricular Pulsatility.
Grinstein J; Torii R; Bourantas CV; Garcia-Garcia HM
ASAIO J; 2021 Jul; 67(7):724-732. PubMed ID: 33528162
[TBL] [Abstract][Full Text] [Related]
4. Targeting Peripheral Vascular Pulsatility in Heart Failure Patients with Continuous-Flow Left Ventricular Assist Devices: The Impact of Pump Speed.
Hydren JR; Kithas AC; Park SH; Wever-Pinzon O; Selzman CH; Perry W; Vargas CAS; Stehlik J; Drakos SG; Richardson RS
ASAIO J; 2020 Mar; 66(3):291-299. PubMed ID: 30973399
[TBL] [Abstract][Full Text] [Related]
5. Association of Clinical Outcomes With Left Ventricular Assist Device Use by Bridge to Transplant or Destination Therapy Intent: The Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) Randomized Clinical Trial.
Goldstein DJ; Naka Y; Horstmanshof D; Ravichandran AK; Schroder J; Ransom J; Itoh A; Uriel N; Cleveland JC; Raval NY; Cogswell R; Suarez EE; Lowes BD; Kim G; Bonde P; Sheikh FH; Sood P; Farrar DJ; Mehra MR
JAMA Cardiol; 2020 Apr; 5(4):411-419. PubMed ID: 31939996
[TBL] [Abstract][Full Text] [Related]
6. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
[TBL] [Abstract][Full Text] [Related]
7. Continuous-flow LVAD exchange to a different pump model: Systematic review and meta-analysis of the outcomes.
Austin MA; Maynes EJ; Gadda MN; O'Malley TJ; Morris RJ; Shah MK; Pirlamarla PR; Alvarez RJ; Entwistle JW; Massey HT; Tchantchaleishvili V
Artif Organs; 2021 Jul; 45(7):696-705. PubMed ID: 33350485
[TBL] [Abstract][Full Text] [Related]
8. Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial.
Vidula H; Takeda K; Estep JD; Silvestry SC; Milano C; Cleveland JC; Goldstein DJ; Uriel N; Kormos RL; Dirckx N; Mehra MR
JACC Heart Fail; 2022 Jul; 10(7):470-481. PubMed ID: 35772857
[TBL] [Abstract][Full Text] [Related]
9. Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study.
Mehra MR; Salerno C; Cleveland JC; Pinney S; Yuzefpolskaya M; Milano CA; Itoh A; Goldstein DJ; Uriel N; Gulati S; Pagani FD; John R; Adamson R; Bogaev R; Thohan V; Chuang J; Sood P; Goates S; Silvestry SC
Circulation; 2018 Oct; 138(18):1923-1934. PubMed ID: 29807933
[TBL] [Abstract][Full Text] [Related]
10. Increased pulsatility index is associated with adverse outcomes in left ventricular assist device recipients.
Tucanova Z; Ivak P; Wohlfahrt P; Pol M; Hlavacek D; Konarik M; Szarszoi O; Netuka I; Pitha J
ESC Heart Fail; 2021 Oct; 8(5):4288-4295. PubMed ID: 34346192
[TBL] [Abstract][Full Text] [Related]
11. De Novo Human Leukocyte Antigen Allosensitization in Heartmate 3 Versus Heartmate II Left Ventricular Assist Device Recipients.
Jain R; Habal MV; Clerkin KJ; Latif F; Restaino SW; Zorn E; Takeda K; Naka Y; Yuzefpolskaya M; Farr MA; Colombo PC; Sayer GT; Uriel N; Topkara VK
ASAIO J; 2022 Feb; 68(2):226-232. PubMed ID: 33883507
[TBL] [Abstract][Full Text] [Related]
12. Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?
Florisson DS; Conte SM; De Bono JA; Newcomb AE
Interact Cardiovasc Thorac Surg; 2019 Dec; 29(6):844-851. PubMed ID: 31436825
[TBL] [Abstract][Full Text] [Related]
13. Improving arterial pulsatility by feedback control of a continuous flow left ventricular assist device via in silico modeling.
Bozkurt S; van de Vosse FN; Rutten MC
Int J Artif Organs; 2014 Oct; 37(10):773-85. PubMed ID: 24970558
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular assist systems and infection-related outcomes: A comprehensive analysis of the MOMENTUM 3 trial.
Patel CB; Blue L; Cagliostro B; Bailey SH; Entwistle JW; John R; Thohan V; Cleveland JC; Goldstein DJ; Uriel N; Su X; Somo SI; Sood P; Mehra MR
J Heart Lung Transplant; 2020 Aug; 39(8):774-781. PubMed ID: 32276809
[TBL] [Abstract][Full Text] [Related]
15. Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.
Uriel N; Colombo PC; Cleveland JC; Long JW; Salerno C; Goldstein DJ; Patel CB; Ewald GA; Tatooles AJ; Silvestry SC; John R; Caldeira C; Jeevanandam V; Boyle AJ; Sundareswaran KS; Sood P; Mehra MR
Circulation; 2017 May; 135(21):2003-2012. PubMed ID: 28385948
[TBL] [Abstract][Full Text] [Related]
16. HeartMate 3 Snoopy: Noninvasive cardiovascular diagnosis of patients with fully magnetically levitated blood pumps during echocardiographic speed ramp tests and Valsalva maneuvers.
Schlöglhofer T; Gross C; Abart T; Schaefer AK; Marko C; Röhrich M; Widhalm G; Kaufmann F; Weigel I; Al Asadi H; Karner B; Riebandt J; Wiedemann D; Laufer G; Schima H; Zimpfer D
J Heart Lung Transplant; 2024 Feb; 43(2):251-260. PubMed ID: 37769887
[TBL] [Abstract][Full Text] [Related]
17. Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients.
Cowger JA; Naka Y; Aaronson KD; Horstmanshof D; Gulati S; Rinde-Hoffman D; Pinney S; Adatya S; Farrar DJ; Jorde UP;
J Heart Lung Transplant; 2018 Jan; 37(1):15-24. PubMed ID: 29153637
[TBL] [Abstract][Full Text] [Related]
18. Early outcomes with durable left ventricular assist device replacement using the HeartMate 3.
Barac YD; Wojnarski CM; Junpaparp P; Jawitz OK; Billard H; Daneshmand MA; Agrawal R; Devore A; Patel CB; Schroder JN; Milano CA
J Thorac Cardiovasc Surg; 2020 Jul; 160(1):132-139.e1. PubMed ID: 31740114
[TBL] [Abstract][Full Text] [Related]
19. Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial.
Kanwar MK; Rajagopal K; Itoh A; Silvestry SC; Uriel N; Cleveland JC; Salerno CT; Horstmanshof D; Goldstein DJ; Naka Y; Bailey S; Gregoric ID; Chuang J; Sood P; Mehra MR
J Heart Lung Transplant; 2020 Jun; 39(6):529-537. PubMed ID: 32279919
[TBL] [Abstract][Full Text] [Related]
20. Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trial.
Mehra MR; Crandall DL; Gustafsson F; Jorde UP; Katz JN; Netuka I; Uriel N; Connors JM; Sood P; Heatley G; Pagani FD
Eur J Heart Fail; 2021 Jul; 23(7):1226-1237. PubMed ID: 34142415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
